Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 247

1.

National survey of drug-resistant tuberculosis in China.

Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, Xia H, Zhou Y, Li Q, Ou X, Pang Y, Song Y, Zhao B, Zhang H, He G, Guo J, Wang Y.

N Engl J Med. 2012 Jun 7;366(23):2161-70. doi: 10.1056/NEJMoa1108789.

2.

Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.

Ramachandran R, Nalini S, Chandrasekar V, Dave PV, Sanghvi AS, Wares F, Paramasivan CN, Narayanan PR, Sahu S, Parmar M, Chadha S, Dewan P, Chauhan LS.

Int J Tuberc Lung Dis. 2009 Sep;13(9):1154-60.

PMID:
19723407
3.

Extensively drug-resistant tuberculosis in california, 1993-2006.

Banerjee R, Allen J, Westenhouse J, Oh P, Elms W, Desmond E, Nitta A, Royce S, Flood J.

Clin Infect Dis. 2008 Aug 15;47(4):450-7. doi: 10.1086/590009.

PMID:
18616396
4.

Epidemiology of drug-resistant tuberculosis in New Jersey from 1991 to 1995.

Liu Z, Shilkret KL, Finelli L.

Int J Epidemiol. 1998 Feb;27(1):121-6.

PMID:
9563705
5.

Multidrug-resistant and extensively drug-resistant tuberculosis in multi-ethnic region, Xinjiang Uygur Autonomous Region, China.

Qi YC, Ma MJ, Li DJ, Chen MJ, Lu QB, Li XJ, Li JL, Liu W, Cao WC.

PLoS One. 2012;7(2):e32103. doi: 10.1371/journal.pone.0032103. Epub 2012 Feb 22.

6.

Prevalence of tuberculosis drug resistance in 10 provinces of China.

He GX, Zhao YL, Jiang GL, Liu YH, Xia H, Wang SF, Wang LX, Borgdorff MW, van der Werf MJ, van den Hof S.

BMC Infect Dis. 2008 Dec 11;8:166. doi: 10.1186/1471-2334-8-166.

7.

Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey.

Al-Hajoj S, Varghese B, Shoukri MM, Al-Omari R, Al-Herbwai M, Alrabiah F, Alrajhi AA, Abuljadayel N, Al-Thawadi S, Zumla A, Zignol M, Raviglione MC, Memish Z.

Antimicrob Agents Chemother. 2013 May;57(5):2161-6. doi: 10.1128/AAC.02403-12. Epub 2013 Mar 4.

8.

[Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].

Ratsirahonana O, Rasolofo Razanamparany V, Rasolonavalona T, Rakotonirina V, Rakotoarisaonina A, Rakotoherisoa A, Ralamboson M, Cauchoix B, Rakotondramarina D, Ramarokoto H.

Arch Inst Pasteur Madagascar. 2002;68(1-2):44-7. French.

PMID:
12643091
9.

Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.

Kim HR, Hwang SS, Kim HJ, Lee SM, Yoo CG, Kim YW, Han SK, Shim YS, Yim JJ.

Clin Infect Dis. 2007 Nov 15;45(10):1290-5. Epub 2007 Oct 15.

PMID:
17968823
10.

Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011.

Ulmasova DJ, Uzakova G, Tillyashayhov MN, Turaev L, van Gemert W, Hoffmann H, Zignol M, Kremer K, Gombogaram T, Gadoev J, du Cros P, Muslimova N, Jalolov A, Dadu A, de Colombani P, Telnov O, Slizkiy A, Kholikulov B, Dara M, Falzon D.

Euro Surveill. 2013 Oct 17;18(42). pii: 20609.

11.

Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Park SK, Kim JH, Kang H, Cho JS, Smego RA Jr.

Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2.

12.

[Prevalence and risk factors on the resistance related to second-line drugs among multi-drug resistant tuberculosis cases in Shanghai, China].

Li J, Zhang YY, Gui XH, Yuan ZA, Pan QC, Mei J, Shen X.

Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Aug;33(8):796-8. Chinese.

PMID:
22967331
13.

[Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].

Augustynowicz-Kopeć E, Zwolska Z, Jaworski A, Kostrzewa E, Klatt M, Swiderska A, Drozd I.

Pneumonol Alergol Pol. 2002;70(3-4):193-202. Polish.

PMID:
12271966
14.

Risk factors associated with kanamycin-resistant tuberculosis in a Beijing tuberculosis referral hospital.

Yu HT, Wang Q, Yang N, Li HM, Liang JQ, Liu CH.

J Med Microbiol. 2012 Jul;61(Pt 7):960-7. doi: 10.1099/jmm.0.042655-0. Epub 2012 Mar 15.

PMID:
22422574
15.

First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.

Tessema B, Beer J, Emmrich F, Sack U, Rodloff AC.

Int J Tuberc Lung Dis. 2012 Jun;16(6):805-11. doi: 10.5588/ijtld.11.0522. Epub 2012 Feb 29.

PMID:
22390880
16.

Pre-XDR & XDR in MDR and Ofloxacin and Kanamycin resistance in non-MDR Mycobacterium tuberculosis isolates.

Jain A, Dixit P, Prasad R.

Tuberculosis (Edinb). 2012 Sep;92(5):404-6. doi: 10.1016/j.tube.2012.05.010. Epub 2012 Jul 11.

PMID:
22789499
17.

Resistance to antituberculosis drugs in rural South Africa: rates, patterns, risks, and transmission dynamics.

Wilkinson D, Pillay M, Davies GR, Sturm AW.

Trans R Soc Trop Med Hyg. 1996 Nov-Dec;90(6):692-5.

PMID:
9015521
18.

[Tuberculosis caused by XDR resistant Mycobacterium tuberculosis in Poland. Microbiological and molecular analysis].

Augustynowicz-Kopeć E, Zwolska Z.

Pneumonol Alergol Pol. 2007;75(1):32-9. Polish.

PMID:
17541910
19.

Population-based surveillance of extensively drug-resistant tuberculosis in Shandong Province, China.

Li X, Wang H, Jing H, Wang Y, Yu C, Wang J, Liu Z, Graviss EA, Ma X.

Int J Tuberc Lung Dis. 2012 May;16(5):612-4. doi: 10.5588/ijtld.11.0507. Epub 2012 Mar 7.

PMID:
22410186
20.

Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.

Prasad R.

Indian J Tuberc. 2010 Oct;57(4):180-91. Review.

PMID:
21141336

Supplemental Content

Support Center